If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Source: bizjournals
Onkaido: Michael Morin joined as Chief Scientific Officer at Onkaido Therapeutics
Read full article »
Onkaido's Competitors
|
Onkaido's News
|
Onkaido's Financials
Follow
Followers on Owler
2
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
President
Steve Kelsey
CEO Approval Rating
73/100
Weigh In
Read more
See Onkaido Therapeutics company profile »
